Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GPR143 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
mRNA | EHD2 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
mRNA | IRAK1BP1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | RPS3A | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | RPL3 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
mRNA | MCM5 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | RBM14 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | ANO10 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
mRNA | RPL5 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | FANCC | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |